TY  - RPRT
TI  - Using a recently approved tumor mutational burden biomarker to stratify patients for immunotherapy may introduce a sex bias
AU  - Sinha, N.
AU  - Sinha, S.
AU  - Cheng, K.
AU  - Madan, S.
AU  - Erez, A.
AU  - Ryan, B.
AU  - Schaffer, A. A.
AU  - Aldape, K.
AU  - Ruppin, E.
PY  - 2021
DO  - 10.1101/2021.05.28.446208
UR  - https://www.biorxiv.org/content/10.1101/2021.05.28.446208v1
ID  - 10.1101/2021.05.28.446208
ER  -